The Global Health Body Issues Alert Over Critical Lack of Weight-Loss Injections

Fewer than one in 10 patients that would benefit from GLP-1 drugs such as Wegovy can access them, warns the global health agency as it publishes its first recommendations on the therapies.

With in excess of 1,000,000,000 people worldwide currently living with obesity, it is advocating for more widespread and fairer availability to GLP-1 medication.

Per forecasts, more than two billion are projected to be living with obesity by 2030 without intervention.

"The latest guidance affirms that excess weight is a chronic disease that can be managed with holistic and lifelong treatment," stated the agency's head Tedros Adhanom Ghebreyesus.

Substantial prices, insufficient output, and supply-chain constraints are significant obstacles to widespread access to the injections that can help people shift substantial body mass, says the agency.

GLP-1 Therapy Scarcity

Even under the present most optimistic case, the manufacturing of these medications would only suffice for about 100 million people – under 10% of those who need them, according to the health organization.

The recommendation urges nations and manufacturers to widen availability, through strategies including voluntary licensing.

A patent on the active ingredient – the core component of Novo Nordisk's Wegovy – is due to expire in a number of nations in 2026.

The Way Obesity Drugs Work

GLP-1 drugs mimick a biological compound to delay gastric emptying, suppress the appetite and boost the sense of being full so individuals eat less.

Individuals typically start to lose weight within a few weeks of starting on the regular doses.

Studies indicates patients may regain a significant portion after a year of discontinuing the treatment, as their usual hunger come back.

To be above a healthy weight elevates your risk for developing health problems, including type 2 diabetes, cardiovascular issues, brain attack, and certain malignancies.

Obesity concerns people in all nations and was responsible for millions of deaths worldwide in 2024, according to the WHO.